MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Cash Flow Overview
Change in Cash
$261,856
Free Cash flow
$288,475
Unit: Dollar
Positive Cash Flow Breakdown
Accounts payable and accrued lia...
Changes in the fair value of der...
Amortization of debt discount
Depreciation and amortization ex...
Negative Cash Flow Breakdown
Net loss
Prepaid expenses
Inventory
Others
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Cash Flow
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Net loss
-2,339,651
-876,274
-1,392,843
-4,353,741
Amortization of debt discount
345,144
729,897
790,014
518,413
Depreciation and amortization expense
90,810
97,694
98,343
76,078
Changes in the fair value of derivative liability
-955,447
1,084,492
921,028
-863
Common shares issued for conversion of note
-
-
22,800
-
Loss on extinguishment of debt
-
-
0
-416,155
Preferred shares issued with debt
-
-
0
0
Accounts receivable
75,423
-8,994
-70,191
77,330
Prepaid expenses
198,709
108,303
8,086
-100,000
Inventory
182,967
138,924
3,391
50,198
Other assets
-
-
5,274
20,000
Other asset
10,000
-
-
-
Accounts payable and accrued liabilities
1,747,323
1,473,532
1,387,470
3,186,028
Cash provided (used) by operating activities
331,974
102,124
38,196
-203,731
Purchase of property and equipment
43,499
315,394
267,172
224,829
Cash used by investing activities
-43,499
-315,394
-267,172
-224,829
Proceeds from issuance of debt
-26,619
318,000
0
0
Cash provided by financing activities
-26,619
318,000
0
0
Net increase in cash
261,856
104,730
-228,977
-428,559
Cash, beginning of period
1,061,448
956,718
1,185,695
1,165,820
Cash, end of period
1,323,304
1,061,448
956,718
1,185,695
Page 1
Unit: Dollar. Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Cash Flow
Accounts payable and
accrued liabilities
$1,747,323
(11.06%↑ Y/Y)
Changes in the fair value
of derivative...
-$955,447
(-64588.35%↓ Y/Y)
Amortization of debt discount
$345,144
(496.47%↑ Y/Y)
Depreciation and
amortization expense
$90,810
(-14.85%↓ Y/Y)
Cash provided (used)
by operating...
$331,974
(161.36%↑ Y/Y)
Canceled cashflow
$2,806,750
Net increase in cash
$261,856
(-41.61%↓ Y/Y)
Canceled cashflow
$70,118
Net loss
-$2,339,651
(-13.26%↓ Y/Y)
Prepaid expenses
$198,709
(88.92%↑ Y/Y)
Inventory
$182,967
(91.44%↑ Y/Y)
Accounts receivable
$75,423
(436.02%↑ Y/Y)
Other asset
$10,000
Cash used by
investing activities
-$43,499
(60.66%↑ Y/Y)
Cash provided by
financing activities
-$26,619
(-102.42%↓ Y/Y)
Purchase of property and
equipment
$43,499
(-60.66%↓ Y/Y)
Proceeds from issuance of
debt
-$26,619
(-102.42%↓ Y/Y)
Buy us a coffee
Regenerative Medical Technology Group Inc. (RMTG)
Regenerative Medical Technology Group Inc. (RMTG)